After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
EBS belongs to the Healthcare sector of the NYSE while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Emergent Biosolutions Inc is $638.64M. A total of 0.55 million shares were traded on the day, compared to an average of 1.04M shares.
In the most recent transaction, LOUIS W SULLIVAN bought 104,695 shares of EBS for 12.77 per share on Dec 22 ’25. In a previous transaction on Dec 05 ’25, Richard Ronald sold 21,984 shares at 11.97 per share. EBS shares that Director owns now total 98,417.
Among the insiders who bought shares, RONALD RICHARD acquired of 32,848 shares on Dec 05 ’25 at a per-share price of $11.94. In another insider transaction, DeGolyer Donald W sold 17,801 shares at $10.54 per share on Nov 10 ’25. Company shares held by the Director now total 119,858.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, EBS has a high of $13.41 and a low of $4.02.
As of this writing, EBS has an earnings estimate of $0.11 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of $0.11 per share and a lower estimate of $0.11. The company reported an EPS of $0.05 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. EBS’s latest balance sheet shows that the firm has $576.10M in Cash & Short Term Investments as of fiscal 2021. There were $841.00M in debt and $374.00M in liabilities at the time. Its Book Value Per Share was $11.05, while its Total Shareholder’s Equity was $1.61B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EBS is Buy with a score of 4.33.
